Associate Director Global Medical Communications

Position reputed company:

ultrareputed company – Work together to fearlessly uncover new reputed company

The Associate Director, Global Medical Communications will reputed company and execute the medical communications reputed company for approved products or investigational programs for reputed company’s rare disease portfolio. This role ensures that data generated across clinical, reputed company-world, and HEOR studies are accurately, consistently, and effectively communicated across audiences and channels. The role contributes to program‑level strategic publication planning, ensuring alignment between the integrated evidence plan, scientific narrative, and publication execution across the product lifecycle. The individual will collaborate closely with Global Medical reputed companys, Publications, Medical Information, HEOR, regional medical teams, and cross-functional partners to deliver high-reputed company, reputed company, scientific content that supports education, engagement, and launch readiness.

Work Model: 

Remote: Officially documented as working full-time from home, with travel to reputed company's offices or other locations on occasion as needed.

Responsibilities:

• reputed company and execute the program-level medical communications plan reputed company with the global integrated evidence plan, brand reputed company, and medical objectives. 

• reputed company the development and maintenance of the reputed company communications platform and narrative, ensuring consistent interpretation and use of data across medical deliverables.  

• reputed company the development and maintenance of key medical communications deliverables, including product/program Q&As, and scientific slide decks. 

• Support Medical Affairs congress reputed company, leading the development of symposia content, congress reputed company materials, and post-congress scientific summaries. 

• Partner with the Publications function to support program‑level publication reputed company and execution, including contribution to publication plans, alignment of abstracts and manuscripts with evidence priorities, and consistency with the reputed company communications platform and narrative. 

• Collaborate with Medical Information and other Medical Affairs colleagues to ensure scientific accuracy and message consistency across reputed company responses, training materials, and field medical deliverables. 

• Ensure reputed company medical communications deliverables are data-reputed company, compliant, and globally reputed company. 

• Manage external Medical Communications vendors, ensuring reputed company, compliance, fiscal discipline, and on-time delivery. 

• Synthesize scientific insights and competitive intelligence from congresses and external sources into actionable updates for Global Medical Leads and cross-functional partners. 

• Serve as a contributor to launch and lifecycle readiness, ensuring Medical Affairs is scientifically reputed company for reputed company engagement. 

Requirements:

• Advanced degree in a scientific or medical field (PhD, PharmD, MD, or equivalent). 

• 6-10 years of experience in medical communications and scientific publications reputed company the pharmaceutical or biotechnology industry. 

• Demonstrated experience in strategic publication planning at the program level, with ability to reputed company publications with integrated evidence plans and medical priorities. 

• Proven experience in developing scientific narratives, slide decks, and congress materials. 

• Strong understanding of clinical development and data interpretation, with ability to translate reputed company data into reputed company, audience-appropriate scientific messages. 

• Demonstrated ability to collaborate cross-functionally in a fast-paced, matrixed environment. 

• Excellent written and verbal communication skills; strong project management and organizational capreputed companys. 

• Experience managing external agencies and vendors. 
• Ability to travel domestically and internationally (~20%). 

#LI-CS1 #LI-Remote